News

Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for its Biologics License Application (BLA) ...
Microchip Expands Space-Qualified FPGA Portfolio with New RT PolarFire® Device Qualifications and SoC Availability
Detailed price information for Microchip Technology (MCHP-Q) from The Globe and Mail including charting and trades.
Apollo Names Brian Chu Head of Apollo Portfolio Performance Solutions
Aaron Miller Named Chairman of APPS, Expected to Retire at End of 2026 NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that Brian Chu has joined the firm as a Partner ...